Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Locke

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Current Cancer Drug Targets|November 25, 2011
Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growthK L Vine, V Indira Chandran, J M Locke, et al.
Genes and Immunity|February 23, 2007
Identification of bidirectional promoters in the human KIR genesG E Davies, S M Locke, P W Wright, et al.
BMC Genomics|September 19, 2013
The splice site variant rs11078928 may be associated with a genotype-dependent alteration in expression of GSDMB transcriptsFaer S Morrison, Jonathan M Locke, Andrew R Wood, et al.
Iscience|March 27, 2023
Mathematical modeling and biochemical analysis support partially ordered calmodulin-myosin light chain kinase bindingMelissa J S MacEwen, Domnita-Valeria Rusnac, Henok Ermias, et al.
Anti-Cancer Drugs|October 1, 2010
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profilesTamantha K Stutchbury, Kara L Vine, Julie M Locke, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1996
Cardiomyoplasty: degeneration of the assisting skeletal muscleC D Ianuzzo, S E Ianuzzo, N Carson, et al.
Anti-Cancer Drugs|July 17, 2009
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinateJulie M Locke, Tamantha K Stutchbury, Kara L Vine, et al.
Frontiers in Cellular Neuroscience|August 28, 2020
Purkinje Cell-Specific Knockout of Tyrosine Hydroxylase Impairs Cognitive BehaviorsTimothy M Locke, Hirofumi Fujita, Avery Hunker, et al.
Pest Management Science|June 13, 2023
Changes in the herbicide sensitivity and competitive ability of Abutilon theophrasti over 28 years: Implications for hormesis and weed evolutionSandra R Ethridge, Saket Chandra, Anna M Locke, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
High-Throughput Identification of Calcium Regulated Proteins Across Diverse ProteomesTimothy M Locke, Rose Fields, Hayden Gizinski, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Current Cancer Drug Targets|November 25, 2011
Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growthK L Vine, V Indira Chandran, J M Locke, et al.
Genes and Immunity|February 23, 2007
Identification of bidirectional promoters in the human KIR genesG E Davies, S M Locke, P W Wright, et al.
BMC Genomics|September 19, 2013
The splice site variant rs11078928 may be associated with a genotype-dependent alteration in expression of GSDMB transcriptsFaer S Morrison, Jonathan M Locke, Andrew R Wood, et al.
Iscience|March 27, 2023
Mathematical modeling and biochemical analysis support partially ordered calmodulin-myosin light chain kinase bindingMelissa J S MacEwen, Domnita-Valeria Rusnac, Henok Ermias, et al.
Anti-Cancer Drugs|October 1, 2010
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profilesTamantha K Stutchbury, Kara L Vine, Julie M Locke, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1996
Cardiomyoplasty: degeneration of the assisting skeletal muscleC D Ianuzzo, S E Ianuzzo, N Carson, et al.
Anti-Cancer Drugs|July 17, 2009
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinateJulie M Locke, Tamantha K Stutchbury, Kara L Vine, et al.
Frontiers in Cellular Neuroscience|August 28, 2020
Purkinje Cell-Specific Knockout of Tyrosine Hydroxylase Impairs Cognitive BehaviorsTimothy M Locke, Hirofumi Fujita, Avery Hunker, et al.
Pest Management Science|June 13, 2023
Changes in the herbicide sensitivity and competitive ability of Abutilon theophrasti over 28 years: Implications for hormesis and weed evolutionSandra R Ethridge, Saket Chandra, Anna M Locke, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
High-Throughput Identification of Calcium Regulated Proteins Across Diverse ProteomesTimothy M Locke, Rose Fields, Hayden Gizinski, et al.
Pageof 23